LOS ANGELES, Sept. 29, 2023 /PRNewswire/ — Glancy Prongay & Murray LLP (“GPM”) announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Apellis Pharmaceuticals, Inc. (“Apellis” or the “Company”) (NASDAQ: APLS). Class…